22nd EVF Scientific Programme

  • 22nd annual Meeting of the European Venous Forum
  • 30 June – 2 July 2022

Provisional Scientific Programme


Please contact Womblab srl with any registration queries. Womblab are acting on behalf of the EVF


Download the Programme/Book of Abstracts



08.00-08.30 Industry Video Session: (5 minute presentation, 5 minute discussion) 3 presentations

Chair: Marzia Lugli

08.30-10.30 Abstract Session 1: Venous Thromboembolism

(10 minute presentation, 10 minute discussion)

Chairs: Oscar Maleti, Andrew Nicolaides

08.30-08.50 1.1 Predictive value of cellular indices for adverse outcomes in VTE patients. Study from RIETE (Registro Informatizado Enfermedad tromboembolica) Registry.

Fakiha Siddiqui*1; Alfonso Tafur2; Mushtaq Hussain3; Alberto García-Orteg4; Pablo Demelo-Rodrígu5; José Antonio Nieto6; Esther Usandizaga7; Jawed Fareed8; Manuel Monreal9

1Loyola University Chicago, Maywood, USA; 2NorthShore University Health Systems, Skokie, USA; 3Dow University of Health Sciences, Karachi, Pakistan; 4Hospital Universitari i Politècnic La Fe, Valencia, Spain; 5Hospital General Universitario Gregorio Marañón, Madrid, Spain; 6Hospital General Virgen de la Luz, Cuenca, Spain; 7Hospital Sant Joan Despí-Moises Broggi, Barcelona, Spain; 8Cardiovascular Research Institute, Loyola University Chicago,, Maywood, USA; 9Hospital Universitari Germans Trias i Pujol., Barcelona, Spain

Submitted for the EVF Prize

08.50-09.10 1.2 Treating acute, subacute, and chronic deep vein thrombosis using mechanical thrombectomy: Six-month outcomes from The United States CLOUT Registry.

Nicolas Mouawad*. McLaren Health System, Bay City, USA

09.10-09.30 1.3 High incidence of thrombosis in patients with severe covid19 infection: LMWH at intermediate doses does not reduce the risk of thrombosis but is associated with lower mortality.

Marta Camats Terré*; Teresa Solanich Valldaura; Granada Perea Duran; Luz Muñoz Marin; Rita Subirana Bofill; Anna Valle Beltran; Anna Artigas Soler; Kinu Reyes Kim; Anna Gasulla Rodríguez; Juan Gabriel Castro Ríos; Juan Carlos Oliva Morera

Parc Taulí Hospital Universitari, Sabadell, Spain

09.30-09.50 1.4 The effects of post-thrombotic venous outflow obstruction on cardiac function during exercise.

Rachael Morris*1; Bram Ruijsink1; Richard Bruce1; Philip Marino2; Bhashkar Mukherjee2; Aimee Brame2; Reza Razavi1; Alberto Smith1; Stephen Black1

1Kings College London, London, UK; 2St Thomas’ Hospital, London, UK

Submitted for the EVF Prize

09.50-10.10 1.5


Long-term results of tinzaparin for the treatment of superficial vein thrombosis of the lower limbs.

Chrysanthi Papageorgopoulou*; Konstantinos Nikolakopoulos; Spyros Papadoulas; Stavros Kakkos. University Hospital of Patras, Patras, Greece

10.10-10.30 1.6 Development of an international standard set of outcome measures for patients with venous thromboembolism: A Report of The International Consortium For Health Outcomes Measurement (ICHOM) Venous Thromboembolism Working Group.

Adam Gwozdz*1; Cindy de Jong2; Luz Fialho3; Frieda Sossi3; Theerawich Likitabhorn4; Stephen Black1; Frederikus Klok2. 1Academic Department of Vascular Surgery, School of Cardiovascular Medicine and Science, King’s Colle, London, UK; 2Department of Medicine, Thrombosis and Haemostasis, Leiden University Medical Center, Leiden, Netherlands; 3International Consortium for Health Outcomes Measurement, London, UK; 4International Consortium for Health Outcomes Measurement, Boston, USA

Submitted for the EVF Prize

10.30-11.00 Refreshments | View ePoster Presentations | Visit Exhibition
11.00-13.00 Abstract Session 2: Venous Thromboembolism

 (10 minute presentation, 10 minute discussion)

Chairs: Stavros Kakkos, Raffaele Pesavento

11.00-11.20 2.1 Sulodexide as a complimentary drug on the management of acute deep venous thrombosis.

Erasto Aldrett Lee*1; Nora Enid Lecuona Huet2

1Hospital Lomas de San Luis, San Luis Potosí, Mexico; 2Hospital Lomas de San Luis, Mexico City, Mexico

11.20-11.40 2.2


Implementation of a direct oral anticoagulant perioperative interruption protocol and accuracy of the DOAC urine dipstick.

Guillermo Tafur*1; Luis Paz Rios2; Thomas Gniadek3; Jeanine Walenga4; Jawed Fareed4; Marisa Durante3; Job Harenberg5; Alfonso Tafur3

1Northwestern University, Evanston, USA; 2Massachusetts General Hospital, Boston, USA; 3NorthShore University Health System, Evanston, USA; 4Loyola University Medical Center, Maywood, USA; 5DOASENSE GmbH, Heidelberg University, Heidelberg, Germany

Submitted for the EVF Prize

11.40-12.00 2.3 Readability of patient educational materials in venous thrombosis. Analysis of the 2021 ESVS guidelines and comparison with other medical societies information.

Enrique San Norberto*1; Álvaro Revilla1; José-Antonio Brizuela1; Manuel Diez1; James Taylor2; Carlos Vaquero1. 1Valladolid University Hospital, Valladolid, Spain; 2Valencia General University Hospital, Valencia, Spain

12.00-12.20 2.4 Predictive Role Of Blood Cellular Indices And Endogenous Glycosaminoglycans As Determinants Of Inflammatory Biomarkers In Acute Pulmonary Embolism.

Fakiha Siddiqui*; Bulent Kantarcioglu*; Amir Darki; Joseph Lewis; Trent Reed; Omer Iqbal; Walter Jeske; Jawed Fareed

Loyola University Chicago, Chicago, USA

12.20-12.40 2.5 Systematic review and meta-analysis of venous thromboembolism prophylaxis after endovenous varicose vein surgery.

Benedict Turner*; Matthew Machin; Sara Jasionowska; Alun H Davies

Charing Cross Hospital, Imperial College London, London, UK

Submitted for the EVF Prize

12.40-13.00 2.6 Impact of standard catheter directed thrombolysis versus ultrasound assisted thrombolysis on total or subtotal pulmonary arterial occlusions in patients with pulmonary embolism. A secondary analysis of the SUNSET Trial.

Efthymios Avgerinos*1; Elizabeth Andraska1; Riyaz Bashir2; Wisam Jaber3; Joan Lacomis1; Michael McDaniel3; Charles Ross4; Rabih Chaer1.

1University of Pittsburgh Medical Center, Pittsburgh, USA; 2Division of Cardiovascular Disease, Lewis Katz School of Medicine at Temple University, Philadelphia, USA; 3Emory University, Atlanta, USA; 4Piedmont Heart Center, Atlanta, USA

13.00-14.00 View ePoster Presentations (4 minute presentations)

Chair: Andrew Nicolaides, Erika Mendoza, Efthymios Avgerinos, Attilo Cavezzi

See separate page for programme

13.00-14.00 Lunch | Visit Exhibition
13.15-14.00 “Meet the Experts” Session

Chairs: Efthymios Avgerinos, Domenico Baccellieri

Iliac stenting: how I do it. Stephen Black (UK)
Thermal vs Non-thermal ablation: when and how I do it. Manjit Gohel (UK)
14.00-15.00 Industry Session 1
15.00-16.00 Didactic Session 1: Advances in the management of acute DVT

Chairs: Niels Baekgaard, A Ierardi



Early Thrombus Removal: who, when and how. Gerard O’Sullivan (Ireland)
15.15-15.30 Acute DVT complicating MT syndrome. Michael Lichtenberg (Germany)
15.30-15.45 Why to be aggressive in young patient affected by DVT. Marzia Lugli (Italy)
15.45-16.00 Which compression in acute DVT and how to apply. Giovanni Mosti (Italy)
16.00-16.30 Refreshments | Visit Exhibition | View ePoster Presentations
16.30-17.30 Didactic Session 2: Advances in the management of chronic venous insufficiency

Chairs: Athanasios Giannoukas, Giovanni Agus

16.30-16.45 Hypodermitis, skin inflammation: how to treat. Lourdes Reina Gutierrez (Spain)
16.45-17.00 How to measure PTS disease and outcomes after operative treatments. Sabina Villalta (Italy)
17.00-17.15 Which pharmacological therapy after stenting. Mario Bazzan (Italy)
17.15-17.30 Chronic venous disease and diabetic microangiopathy: pathophysiology and commonalities. Marie Josee van Rijn (Netherlands)
17.30-18.30 Industry Session 2



08.00-08.30 Industry Video Session: (5 minute presentation, 5 minute discussion) 3 presentations

Chair: Giovanni Lipari (Italy)

08.30-10.30 Abstract Session 3: Iliac occlusion and pelvic congestion syndrome, Cyanoacrylate, Epidemiology

 (10 minute presentation, 10 minute discussion)

Chairs: Dominik Heim, Gennaro Quarto

08.30-08.50 3.1 Patency rates and predictors for re-intervention after stenting for acute or chronic deep vein thrombosis: a retrospective observational study.

Jay M. Bakas*; Adriaan Moelker; Catherine van Montfrans; Marie Josee E. van Rijn

Erasmus Medical Center, Rotterdam, Netherlands

Submitted for the EVF Prize

08.50-09.10 3.2 Identification of patients with outflow obstruction most likely to benefit from iliac stenting.

Fedor Lurie*. Jobst Vascular Institute, Toledo, USA

09.10-09.30 3.3 Hybrid ilio-femoral recanalization after injection for drug abuse obstruction: a single centre experience.

Elisa Munari*; Marzia Lugli; Matteo Longhi; Oscar Maleti. Hesperia Hospital, Modena, Italy

Submitted for the EVF Prize

09.30-09.50 3.4 Endovascular treatment of pelvic congestive syndrome, literature review. Is pharmacomechanical ablation of gonadal veins an alternative to classic embolization?

Eliseo Candela Beltran*. Hospital de Manises, Valencia, Spain

Submitted for the EVF Prize

09.50-10.10 3.5 Evolution of the epidemiology and management of chronic venous disease in the UK.

Safa Salim*1; Mahsa Mazidi1; Roberto Fernandez Crespo1; Estelle Collin2; Sarah Onida1; Joanna Chirol2; Alun H Davies1. 1Imperial College London, London, UK; 2Servier, Paris, France

Submitted for the EVF Prize

10.10-10.30 3.6 Correlation Amongst Transvaginal And Transabdominal Duplex And CT Angiogram For Pelvic Venous Insufficiency And Leg Varicosities

Lourdes Reina Gutierrez*1; Angel Sanchez Guerrero2; Luis Albeniz1; Jose Ignacio Fernandez Solares1; Agnieszka Nowak Tarnawska1; Carlos Barrio Rodriguez1; Angela Miguel Morrondo1; Aurora Florez-Gonzalez1; Alfonso Sanjuanbenito-Reina3; Jose Antonio Gonzalez-Fajardo2;

1Hospital Central de la Cruz Roja, Madrid, Spain; 2Hospital Universitario 12 de Octubre, Madrid, Spain; 3Universidad Autonoma, Madrid, Spain

10.30-11.00 Refreshments | View ePoster Presentations | Visit Exhibition
11.00-12.00 Industry Session 3
12.00-12.30 EVF Invited Lecture

Chair: Oscar Maleti (Italy)

Introduction by Oscar Maleti

COVID-19 and Thrombosis: basis and management of an incendiary duality. Ismail Elalamy (France)
12.30-13.00 Didactic Session 3: Guidelines of Chronic Venous Disease

Chairs: Tomasz Urbanek, Gaetano Lanza

12.30-12.45 Comparison of recent guidelines for Chronic Venous Disease. Dominik Heim (Switzerland)
12.45-13.00 What is not in the Guidelines. Imre Bihari (Hungary)
13.00-14.00 Refreshments | View ePoster Presentations (4 minute presentations)

Chairs: Andrew Nicolaides, Erika Mendoza, Efthymios Avgerinos, Attilo Cavezzi

See separate page for programme

13.15-14.00 Industry Workshop
13.00-14.00 Visit Exhibition
14.00-15.00 EVF Annual General Meeting (Members Only)
15.00-16.00 Joint EVF/AVF Session Debate:

Chairs: Marianne Vandendriessche, Lugli Marzia

15.00-15.30 Evaluation of patients with CVI should include pelvic venous imaging in addition to lower extremity imaging.

For: Kathleen Ozsvath (USA), AVF | Against: Armando Mansilha (Portugal) EVF



Venoactive drugs are useful in the management of patients with chronic venous disease in all stages of CEAP.

For: Andrew Nicolaides, EVF | Against: Nicos Labropoulos (AVF)

16.00-16.30 Refreshments| Visit ePoster Presentations | Visit Exhibition
16.30-17.30 Industry Session 4
17.30-18.30 Prize winning papers from the Japanese Society of Phlebology, American Venous Form and American Vein and Lymphatic Society

(10 minute presentation, 10 minute discussion)

Chairs: Erika Mendoza, Angelo Santoliquido



Incidence and Clinical Features of Venous Thromboembolism in Hospitalized Patients with COVID-19 in Japan

Yugo Yamashita: Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Norikazu Yamada: Department of Cardiology, Kuwana City Medical Center, Kuwana, Japan

Mo Makoto: Department of Cardiovascular Surgery, Yokohama Minami Kyosai Hospital, Kanagawa, Japan

JSP Prize paper

17.50 Is Oedema Underrecognized in Superficial Venous Disease Patients?

Sophia C. Weldon, Christopher Pittman, Stachyse Stanis, Anna M. Wright.

Vein911 Vein Treatment Centers, Tampa, Florida, USA

AVLS Prize Paper

18.10 Markers of pulmonary hypertension in patients with submassive pulmonary embolism undergoing catheter thrombolysis compared to anticoagulation alone: a secondary analysis of the SUNSET sPE trial.

Andraska EA1, Bonaroti J2, Zhang Y3, Rivera-Lebron B3, Chaer RA1, Avgerinos ED1 

1UPMC, Department of Surgery, Division of Vascular Surgery; Pittsburgh, Pennsylvania, United States

2UPMC, Department of Surgery; Pittsburgh, Pennsylvania, USA

3UPMC, Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine; Pittsburgh, Pennsylvania, USA

AVF Prize paper



08.30-10.30 Abstract Session 4: Compression, microcirculation, telangiectasia, varicose veins

(10 minute presentation, 10 minute discussion)

Chairs: Imre Bihari, Marco Viani

08.30-08.50 4.1 A randomized trial of moderate (class 2), high (class 3) and very high (class 4) elastic compression in the prevention of recurrence of venous ulceration.

Dragan Milic*1; Sasa Zivic2; Milan Lazarevic1; Dragan Bogdanovic3; Bekim Ademi4; Isidora Milic5. 1University Clinical Centre Nis, Medical school University of Nis, Nis, Serbia; 2University Clinical Centre Nis, Nis, Serbia; 3University of Novi Pazar, Novi Pazar, Serbia; 4Clinical Centre Pristina, Kosovo*, Presevo, Serbia; 5Medical school University of Nis, Nis, Serbia

08.50-09.10 4.2 COmpressioN Following Endovenous TreatmenT of Incompetent Varicose Veins (CONFETTI).

A Belramman*; R Bootun; TRA Lane; CV Riga; C Aylwin; J Shalhoub; U Jaffer; C Bicknell; AH Davies. Imperial College London, London, UK

Submitted for the EVF Prize

09.10-09.30 4.3 Microcirculatory alterations in chronic venous disorder — Observation in C0s patients (CEAP Classification).

Eliete Bouskela*1; Bernardo Cunha Senra Barros2; Carlos Eduardo Virgini Magalhães1; Daniel Alexandre Bottino1. 1State University of Rio de Janeiro, Rio de Janeiro, Brazil; 2Federal University of Rio de Janeiro State, Rio de Janeiro, Brazil

09.30-09.50 4.4 Prevalence of chronic venous disease in primary care centers in Azerbaijan: The VEINSCOPE Study.

Farhad Aghayev*. Baku Phlebological Center, Baku, Azerbadijan

09.50-10.10 4.5


Frequency of postoperative neuropathies after phlebectomy and minimal invasive treatment methods for varicose veins

Anna Ūdre*1; Solvita Bērziņa2; Patricija Ivanova3; Ints Ūdris3 1Riga East Clinical University Hospital, University of Latvia, Riga, Latvia; 2Riga East Clinical University Hospital, Riga, Latvia; 3Riga East Clinical University Hospital, Baltic Vein Clinic, University of Latvia, Riga, Latvia
Submitted for the EVF Prize

10.10-10.30 4.6 N-butyl-2-cyanoacrylate glue ablation as a single-catheter procedure for the great saphenous vein insufficiency treatment – 5-years follow-up.

Michal Juszynski*; Jan Wawszczak; Grzegorz Madycki. Centre of Postgraduate Medical Education, Warsaw, Poland

Submitted for the EVF Prize

10.30-11.00 View ePoster Presentations and visit Exhibition
11.00-13.00 Abstract Session 5: Congenital malformation, lymphatics, complications of thrombolysis, obesity, AI Guidance

(10 minute presentation, 10 minute discussion)

Chairs: Armando Mansilha, Francesco Stillo

11.00-11.20 5.1 Remote expert DVT triaging of novice-user compression sonography with AI guidance.

Jonas Oppenheimer1; Ramin Mandegaran2; Sven Mischkewitz1; Fouad Al Noor3; Andrea Adler4; Stephan Singöhl4; Mattias Heinrich5; Bernhard Kainz6; Stavros Spiliopoulos7; George Geroulakos7; Efthymios Avgerinos*7

1ThinkSono GmbH, Potsdam, Germany; 2Central Alberta Medical Imaging Services, Red Deer, Canada; 3ThinkSono GmbH, London, UK; 4Klinikum Magdeburg, Magdeburg, Germany; 5University of Lübeck, Lübeck, Germany; 6FAU Erlangen-Nürnberg, Erlangen, Germany; 7Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece

11.20-11.40 5.2


Benefit of an adjustable compression system for the reduction of oedema (akro study)- preliminary results.

Gabriele Faerber*1; Birgit Kahle2; Tobias Hirsch3; Andrzej Szuba4

1Zentrum für Gefäßmedizin, Hamburg, Hamburg, Germany; 2Universitäts-Klinikum Schleswig-Holstein Campus Lübeck, Luebeck, Germany; 3Praxis für Innere Medizin und GEfaesskrankheiten, Halle, Germany; 4Uniwersytecki Szpital Kliniczny im.Jana Mikulicza-Radeckiego we Wrocławiu, Wroclav, Poland

11.40-12.00 5.3 Effect of ruscus extract, hesperidin methyl chalcone and vitamin C on human lymphatic smooth muscle cells contraction.

Nicolas Monjotin*1; Guillaume Tenca1Castres, France; 2QIMA Life Sciences, Gencay, France

12.00-12.20 5.4 Peri-operative management of anticoagulation and bleeding in patients undergoing CDT for acute iliofemoral DVT.

Katherine Creeper*; Katie White; Stephen Black; Narayanan Thulasidasan; Karen Breen. Guy’s and St Thomas’ NHS Foundation Trust, London, UK

12.20-12.40 5.5 A Systematic Review Of Compression Following Treatment Of Superficial Venous Incompetence

Abduraheem Mohamed1; Sundus Mohamed*2; Simran Thadani3; Misha Sidapra1; George Smith1; Ian Chetter1; Daniel Carradice1

1Hull University Teaching Hospitals, Hull, UK; 2Leeds University Teaching Hospitals, Leeds, UK; 3Hull York Medical School, Hull, UK

Submitted for the EVF Prize

12.40-13.00 5.6


Stenting Of Non-thrombotic Iliac Vein Lesions: Long-term Patency Rate

Matteo Longhi*; Marzia Lugli; Elisa Munari; Oscar Maleti. Hesperia Hospital, Modena, Italy

13.00-14.00 Didactic Session 4: Management of lymphatic disorders

Chairs: Oscar Maleti, Albert Claude Benhomou

13.00-13.15 Quality of life after vascularised lymph node transfer or lymphovenous anastomosis in patients with lower limb lymphoedema — a systematic review. Sarah Onida (UK)
13.15-13.30 Lymphoscintigraphic pattern in CEAP 0s: Role Of deep lymphatic circulation. Alberto Maccio (Italy)
13.30-13.45 Role of the vein in the long-term patency of microsurgical lymphatic-venous by-pass (LVB) surgery in lymphedema treatment. Francesco Boccardo (Italy)
13.45-14.00 Differential diagnosis of venous ulcer. If it is not a venous ulcer, what is it? Daciana Branisteanu (Romania)
14.00 Presentation of EVF Prizes. Oscar Maleti

Presentation of 2023 Meeting. Erika Mendoza

End of meeting

Comments are closed.